Factors reported to be involved in the development and progression of NAFLD include interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and C-reactive protein (CRP) (13–15). The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.